March 6, 2012 – Accelitech and partners have just completed a transaction to bring the first and only
CyberKnife stereotactic radiosurgery system to the Republic of Ireland. Scheduled to begin treating
patients in fall of 2012, the center will open on the campus of the Hermitage Medical Clinic in Dublin.

The partnership includes the following parties: Accelitech (lead developer), Neurosurgery Ireland (a
prominent Irish neurosurgical group), Regent Surgical Health (a developer of high-end specialized
surgical programs), the Hermitage Medical Clinic and several other local providers, all of whom share
the vision and interest in bringing this state-of-the-art cancer treatment technology to the people of
Ireland.

Historically, Irish patients requiring CyberKnife radiosurgery treatments—and in many cases their
treating neurosurgeons — have been required to travel to other countries to complete treatments.

"This partnership is a big win for the people of Ireland," says Scott Milligan, chief development officer
for Accelitech. "The new CyberKnife program will combine the very best clinical teams in the country
with the latest advanced technology in a conveniently located, patient-focused facility."

For more information: www.accelitech.biz


Additional Content

News | Radiology Business

April 10, 2026 — The radiation therapy team at The Ohio State University Wexner Medical Center, The James Cancer ...

Time April 10, 2026
arrow
News | Radiology Imaging

April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the ...

Time April 09, 2026
arrow
News | FDA

March 20, 2026 — Siemens Healthineers recently announced its Varian TrueBeam radiotherapy systems, which include ...

Time March 24, 2026
arrow
News | Radiology Education

March 17, 2026 – The Center for Radiology Education (CRE) has announced a nationwide initiative to provide scholarships* ...

Time March 17, 2026
arrow
News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
Subscribe Now